Latest News about BMY
Recent news which mentions BMY
The Daily Biotech Pulse: J&J Pauses Coronavirus Vaccine Studies, Voyager's Huntington's Disease Study Placed On Hold, Altimmune Vaccine Data
October 13, 2020
From Benzinga
The Week Ahead In Biotech: J&J Earnings Kickstarts Pharma Earnings, More IPOs In The Pipeline
October 11, 2020
From Benzinga
Here's Why Bristol Myers Offered MyoKardia $13.1 Billion
October 07, 2020
From Motley Fool
The Daily Biotech Pulse: Bristol-Myers Squibb's Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences
October 07, 2020
From Benzinga
These Are the 3 Biggest Bargains in Biotech
October 07, 2020
From Motley Fool
Myokardia Analysts See Mavacamten As Blockbuster Opportunity For Bristol-Myers Squibb
October 06, 2020
From Benzinga
Why Exelixis Jumped 10% in September
October 06, 2020
From Motley Fool
From Benzinga
From MarketWatch
Mid-Afternoon Market Update: Dow Surges 350 Points; Eidos Therapeutics Shares Spike Higher
October 05, 2020
From Benzinga
Bristol Myers Squibb Begins a $13.1 Billion Purchase of MyoKardia
October 05, 2020
From Motley Fool
Stock Markets Soar as Coronavirus Stocks Stay in the Spotlight
October 05, 2020
From Motley Fool
From Benzinga
Mid-Morning Market Update: Markets Open Higher; Bristol-Myers Squibb To Acquire MyoKardia For $13B
October 05, 2020
From Benzinga
Why MyoKardia Stock Is Soaring Today
October 05, 2020
From Motley Fool
Bristol-Myers Squibb Beefs Up Cardiology Franchise With $13.1B Deal To Buy Myokardia
October 05, 2020
From Benzinga
Got $500? Here Are 2 Stocks That Could Soar
October 04, 2020
From Motley Fool
Next Coronavirus Market Crash: Where to Invest $10,000
October 03, 2020
From Motley Fool
Market Crash 2.0: 3 Stocks to Save Your Portfolio
October 03, 2020
From Motley Fool
5 Safe Stocks to Buy if the Stock Market Crashes
October 03, 2020
From Motley Fool
Tickers
BMY
From Motley Fool
Congressional Committee Accuses Amgen and Peers of Hiking Drug Prices to Meet "Aggressive" Revenue Targets
October 02, 2020
From Motley Fool
FDA broadens U.S. safety inquiry into AstraZeneca COVID-19 vaccine, Reuters reports
October 01, 2020
From MarketWatch
Benzinga's Top Upgrades, Downgrades For September 29, 2020
September 29, 2020
From Benzinga
34 Stocks Moving in Friday's Pre-Market Session
September 25, 2020
From Benzinga
6 Stocks Moving In Thursday's After Hours Session
September 24, 2020
From Benzinga
10 Biggest Price Target Changes For Tuesday
September 22, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.